scispace - formally typeset
R

Regina Cencic

Researcher at McGill University

Publications -  63
Citations -  2923

Regina Cencic is an academic researcher from McGill University. The author has contributed to research in topics: Eukaryotic translation & Eukaryotic initiation factor. The author has an hindex of 27, co-authored 62 publications receiving 2501 citations. Previous affiliations of Regina Cencic include University of Vienna & Boston University.

Papers
More filters
Journal ArticleDOI

Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol.

TL;DR: In this article, the authors presented the results of the Canadian Institutes of Health Research (CIHR) Training Grant and the US Lymphoma Foundation Training Grant (USLGF).
Journal ArticleDOI

Structural conservation of druggable hot spots in protein–protein interfaces

TL;DR: The structural and physicochemical signature of druggable sites at PPI interfaces is sufficiently robust to be detectable from the structure of the unliganded protein, even when substantial conformational adaptation is required for optimal ligand binding.
Journal ArticleDOI

Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F

TL;DR: An ultra-high-throughput screen to identify inhibitors that prevent assembly of the eIF4F complex is undertaken and this compound can reverse tumor chemoresistance in a genetically engineered lymphoma mouse model by sensitizing cells to the proapoptotic action of DNA damage.
Journal ArticleDOI

c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation

TL;DR: The results suggest the presence of a feedforward loop involving c-Myc and eIF4F that serves to link transcription and translation and that could contribute to the effects of c- myc on cell proliferation and neoplastic growth.
Journal ArticleDOI

Repurposing CRISPR/Cas9 for in situ functional assays

TL;DR: The results establish Cas9 genome editing as a powerful and practical approach for positive in situ genetic screens for targeted gene disruption positive selection assays.